Discovery of a selective PI3Kα inhibitor via structure-based virtual screening for targeted colorectal cancer therapy
{{output}}
Colorectal cancer (CRC) remains a leading cause of cancer-related mortality globally, driving an urgent need for effective therapies. A promising avenue of research focuses on the PI3K/AKT/mTOR signalling pathway, which is frequently disrupted by mutations in ... ...
